TerminatedNot Applicable

Allosure in Simultaneous Pancreas Kidney Transplant

Stopped: slow enrollment

United States13 participantsStarted 2021-02-26

Plain-language summary

This study will observe donor derived cell free DNA percentages (via the Allosure test) in combined kidney-pancreas transplant recipients to establish both stable and dysfunctional Allosure assay levels

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years * Kidney-pancreas transplant recipients * Patient must have stable creatine, lipase, amylase for at least a two month span after transplant OR patient must receive a biopsy within one year post transplant Exclusion Criteria: * Presence of non-renal or pancreas transplanted organ * Patient is not enrolled within 1 year after transplant

What they're measuring

DD-cfDNA level

Timeframe: 1 year

Trial details

NCT IDNCT04777617

SponsorWashington University School of Medicine

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-07-31

View on ClinicalTrials.gov More Kidney Pancreas Transplant trials